A Look at Charles River Laboratories International Inc (CRL) After 9.3% Gain -- GF Value $194.24 vs Price $344.87
gurufocus.com · 2026-10-21
On October 21, 2026, Charles River Laboratories International Inc (CRL) shares rose 9.3% to $344.87, continuing a strong upward trend with a year-to-date gain o
TickrTrends take: Charles River Laboratories stock has risen significantly, but TickrTrends currently assesses it as overvalued relative to its fundamental metrics. The gap between the GF Value estimate and the current trading price suggests the stock may be priced above levels supported by its underlying business performance. Investors focused on valuation should monitor whether the company's earnings growth justifies the current premium, particularly given the competitive dynamics within the Healthcare sector.
Read the full story at gurufocus.com →
Is CRL undervalued? See TickrTrends' fair value analysis →